Pharmacological correction of misfolding of ABC proteins

Citations of this article
Mendeley users who have this article in their library.


The endoplasmic reticulum (ER) quality control system distinguishes between correctly and incorrectly folded proteins to prevent processing of aberrantly folded conformations along the secretory pathway. Non-synonymous mutations can lead to misfolding of ABC proteins and associated disease phenotypes. Specific phenotypes may at least partially be corrected by small molecules, so-called pharmacological chaperones. Screening for folding correctors is expected to open an avenue for treatment of diseases such as cystic fibrosis and intrahepatic cholestasis. © 2014 The Authors.




Rudashevskaya, E. L., Stockner, T., Trauner, M., Freissmuth, M., & Chiba, P. (2014). Pharmacological correction of misfolding of ABC proteins. Drug Discovery Today: Technologies. Elsevier Ltd.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free